Schizophrenia Study News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Schizophrenia Study. Real-time updates on events, politics, business and more.

Antipsychotic Polypharmacy and Metabolic Disorder Risk in Individuals With Schizophrenia

December 16, 2023

What are the cardiometabolic risks of polypharmacy with quetiapine and long-acting injectable paliperidone in patients with schizophrenia?

United States United Kingdom Stanley Medical Research Institute Augusta University Department Of Psychiatry Mental Health Services Data

Source: psychiatrictimes.com

Antipsychotic Polypharmacy and Risk of Metabolic Disorders in Schizophrenia

October 9, 2023

What is the risk of diabetes, hypertension, or hyperlipidemia with antipsychotic polypharmacy in patients with schizophrenia? Researchers investigated these associations in a population-based prospective cohort study.

United Kingdom United States United Kingdom Clinical Practice Research Datalink Augusta University Mental Health Services Dataset Health Behavior At Augusta University

Source: psychiatrictimes.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Schizophrenia Study News Today

Antipsychotic Polypharmacy and Metabolic Disorder Risk in Individuals With Schizophrenia

Antipsychotic Polypharmacy and Risk of Metabolic Disorders in Schizophrenia

Explore More Categories